CALQUENCE 100 MG Oral Tablet
- RxCUI
- 2607737
- RxNorm name
- CALQUENCE 100 MG Oral Tablet
- Display name
- CALQUENCE 100 MG Oral Tablet
- Full name
- CALQUENCE 100 MG Oral Tablet
- Term type
- PSN
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:16
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| CALQUENCE | ACALABRUTINIB | AstraZeneca Pharmaceuticals LP | b1409184-3267-4d8c-8f17-4e01f69828b1 | 2026-02-19 | Warnings, Adverse reactions | 2607737 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm string | TTY | SPL version | Label | Effective |
|---|---|---|---|---|---|
| b1409184-3267-4d8c-8f17-4e01f69828b1 | CALQUENCE 100 MG Oral Tablet | PSN | 8 | These highlights do not include all the information needed to use CALQUENCE safely and effectively. See full prescribing information for CALQUENCE. CALQUENCE ® (acalabrutinib) tablets, for oral use Initial U.S. Approval: 2017 | 20260219 |
| b1409184-3267-4d8c-8f17-4e01f69828b1 | acalabrutinib 100 MG Oral Tablet [Calquence] | SBD | 8 | These highlights do not include all the information needed to use CALQUENCE safely and effectively. See full prescribing information for CALQUENCE. CALQUENCE ® (acalabrutinib) tablets, for oral use Initial U.S. Approval: 2017 | 20260219 |
| b1409184-3267-4d8c-8f17-4e01f69828b1 | Calquence 100 MG Oral Tablet | SY | 8 | These highlights do not include all the information needed to use CALQUENCE safely and effectively. See full prescribing information for CALQUENCE. CALQUENCE ® (acalabrutinib) tablets, for oral use Initial U.S. Approval: 2017 | 20260219 |